MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹273 Cr | ₹205 Cr | ₹84 Cr | ₹57 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹24 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | 33.00 | |
| Mar2024 | ₹205 Cr | 143.34 | |
| Mar2023 | ₹84 Cr | 47.80 | |
| Mar2022 | ₹57 Cr | 140.72 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹12,093.6 Cr | -1.5% | 2.1% | 4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -1.5% |
2.1% |
4.9% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses